As a leading healthcare market research agency, AplusA has extensive experience researching diseases within hemato-oncology.
Hemophilia management is evolving as several new therapies for the treatment of both Hemophilia A and Hemophilia B are being launched or studied in clinical trials. Capitalizing on our unique expertise in patient chart-based research, the results from each wave of this study are based on real world data and monitor the impact of the new treatments for Hemophilia management. The latest wave of this study was conducted in 2020.
Fill in the form to access an overview of our Hemophilia A&B syndicated study including:
- Types of data collected
- Dates of research waves